1. Optimizing Outcomes in Short Bowel Syndrome With IF

2. SBS-IF: Introduction

3. SBS-IF: Goals of Therapy

4. Case Presentation: Mark

5. Patient Presentation

6. Patient Presentation (cont)

7. Laboratory Measurements

8. Next Step?

9. Abdominal and Pelvic CT

10. Next Step?

11. Laparotomy

12. Surgical Repair

13. Mark: Clinical Assessment

14. What Length of Small Bowel Is Required For a Patient to Be Independent From PS?

15. PS Prognosis

16. Mark: Clinical Assessment (cont)

17. ESPEN Guidelines on Chronic IF in Adults

18. Overall Treatment Strategy for Patients With SBS-IF

19. Treatment of Patients With SBS-IF

20. Treatment of Patients With SBS-IF (cont)

21. Treatment of Patients With SBS-IF (cont)

22. Treatment of Patients With SBS-IF (cont)

23. Treatment of Patients With SBS-IF: Summary

24. Teduglutide: A GLP-2 Analog

25. STEPS: Primary Endpoint -- Greater Than 20% Reduction in PN/IV Fluids

26. Teduglutide: Indications

27. Surgical Treatment of Patients With SBS

28. Practical Considerations for Identifying Suitable Patients for Teduglutide in Clinical Practice

29. Effect of Teduglutide by Bowel Anatomy

30. Mark: Alternatives to Teduglutide Treatment

31. Oversight of Management Strategy and Multidisciplinary Teams in Intestinal Rehabilitation

32. Conclusions

33. Abbreviations